HKU gets early boost in race for medical students
Thirty-one of the 57 students accepted early for the University of Hong Kong's medical programme came through the School Nominations Direct Admission Scheme. Photo: RTHK
The University of Hong Kong's faculty of medicine said on Monday it has already filled a sixth of its undergraduate programme enrolment quota for the upcoming academic year ahead of Wednesday's release of Diploma of Secondary Education (DSE) examination results.
The 57 students received unconditional offers through different schemes, namely the School Nominations Direct Admission Scheme (SNDAS) and IB Diploma programme.
It said 31 students were from the SNDAS – a program rolled out by the Education Bureau in the 2022-23 academic year.
This was up from 21 and 24 students in 2023 and 2024, respectively.
'This is the third year that we have SNDAS students reading medicine,' said assistant dean Kenny Kwan.
"Through the experience of the past two years, we are able to understand more about the criteria [that we need to set] for students being recommended by their schools and principals.
'We have more confidence that these students can excel in our medical school programme.
"Through that we are able to increase the number of candidates."
Kwan said one of them was from Minxin School in Guangzhou – which participated in the DSE examination for the first time.
The faculty also said all 25 spots have been filled in its second-degree programme, which allows students to complete their studies in four years.
It said more than 950 applications were received, with almost 80 percent of the applicants having a biomedical sciences-related background.
Kwan said the programme is very attractive for both overseas and local students.
'This is a shorter programme – four years for them to finish the medical degree – and also gives them a second chance to pursue medicine, as some school leavers at that stage may not have made up their minds,' he said.
'So this provides them with a valuable route if they want to study medicine and become doctors.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
HKFP
a day ago
- HKFP
Chikungunya fever poses ‘medium to high risk' of local transmission, warns Hong Kong health official
The mosquito-borne chikungunya fever poses a 'medium to high risk' of local transmission in Hong Kong, as thousands of cases were reported in the neighbouring Guangdong province, a city health official has warned. Albert Au, head of the Communicable Disease Branch of the Centre for Health Protection (CHP), said on an RTHK radio show on Thursday that Guangdong province had seen a 'localised outbreak' of chikungunya fever over the past few weeks following some imported cases. Based on the CHP's communication with Guangdong authorities, the southern Chinese province has logged around 6,100 cases so far, Au said. About 90 per cent of the cases were recorded in Foshan, but other cities such as Guangzhou, Zhongshan, and Dongguan have reported cases too, he added. While Hong Kong has not recorded any cases so far, authorities are 'on high alert,' Au said. 'It is a time for summer holidays, and Hongkongers love to travel to Guangdong province. With frequent travel, there is a high risk of imported cases,' the health official said. 'Hong Kong has more mosquitoes during summer,' he added. 'So if there are imported cases, there is a medium to high risk that it will lead to local transmission.' According to the CHP, chikungunya fever is most commonly transmitted to humans through the bites of infected female Aedes mosquitoes. While the vector Aedes aegypti is not found in Hong Kong, Aedes albopictus, another species that can also spread the disease, is commonly found in the city. Chikungunya fever causes rare fatalities, and its symptoms are milder than those of dengue fever, another mosquito-borne disease. However, chikungunya fever carries a higher transmission potential than dengue fever, Au said. Mosquito control measures Meanwhile, the Housing Department has stepped up measures to prevent and control mosquitoes in public housing estates in Hong Kong due to the chikungunya outbreak in Guangdong. According to a statement on Thursday, the department is conducting fogging operations to eliminate adult mosquitoes and has taken measures such as removing stagnant water and water-holding containers and keeping drains clear of blockages to prevent water accumulation.
RTHK
a day ago
- RTHK
Govt doubles subsidised drug list for chronic diseases
Govt doubles subsidised drug list for chronic diseases The Health Bureau says it's doubling the number of subsidised drugs under its chronic disease pilot scheme to cater to patients' demands. Photo: RTHK The government on Friday said it had almost doubled the number of drugs it subsidises under a pilot scheme, so that more medicines can be used by participating doctors to cater to patients' needs. The announcement came after the Health Bureau conducted a review to learn more about the demands of patients under the "Chronic Disease Co-care Pilot Scheme (CDCC Pilot Scheme)" that was launched almost two years ago. In a statement, the bureau said the coverage of its subsidised basic-tier drug list had been expanded from 59 to 114 items - starting on Friday. The drugs on the list are commonly used for treating chronic diseases such as diabetes, high blood pressure, and high blood cholesterol. Newly added drugs, meanwhile, include antidepressants, or medicines for managing chronic hepatitis B, osteoporosis, thyroid disorder, as well as medication to relieve asthma, gout, nausea, and dizziness. Under the scheme, patients prescribed with drugs on the list will not need to pay for such medication. And the drugs will form the "foundation" of the community drug formulary set to be launched in the future, which would be key in supporting the operation of the community pharmacy scheme. Launched in November 2023, as part of measures to improve Hong Kong's primary medical care, the pilot scheme provides subsidised screening services to residents aged 45 or above to detect if they have the so-called "three highs": high blood sugar, high blood pressure, and high blood cholesterol. Participating patients who are diagnosed with any of those conditions will receive subsidised treatment and medication. So far, some 140,000 participants have enrolled in the scheme, with over 85,000 of them already completing their screenings, and some 34,000 have been diagnosed with long-term diseases related to the "three highs".
RTHK
a day ago
- RTHK
Govt doubles subsidised drug list for chronic diseases
Govt doubles subsidised drug list for chronic diseases The Health Bureau says it's doubling the number of subsidised drugs under its chronic disease pilot scheme to cater to patients' demands. Photo: RTHK The government on Friday said it had almost doubled the number of drugs it subsidises under a pilot scheme, so that more medicines can be used by participating doctors to cater to patients' needs. The announcement came after the Health Bureau conducted a review to learn more about the demands of patients under the "Chronic Disease Co-care Pilot Scheme (CDCC Pilot Scheme)" that was launched almost two years ago. In a statement, the bureau said the coverage of its subsidised basic-tier drug list had been expanded from 59 to 114 items - starting on Friday. The drugs on the list are commonly used for treating chronic diseases such as diabetes, high blood pressure, and high blood cholesterol. Newly added drugs, meanwhile, include antidepressants, or medicines for managing chronic hepatitis B, osteoporosis, thyroid disorder, as well as medication to relieve asthma, gout, nausea, and dizziness. Under the scheme, patients prescribed with drugs on the list will not need to pay for such medication. And the drugs will form the "foundation" of the community drug formulary set to be launched in the future, which would be key in supporting the operation of the community pharmacy scheme. Launched in November 2023, as part of measures to improve Hong Kong's primary medical care, the pilot scheme provides subsidised screening services to residents aged 45 or above to detect if they have the so-called "three highs": high blood sugar, high blood pressure, and high blood cholesterol. Participating patients who are diagnosed with any of those conditions will receive subsidised treatment and medication. So far, some 140,000 participants have enrolled in the scheme, with over 85,000 of them already completing their screenings, and some 34,000 have been diagnosed with long-term diseases related to the "three highs".
